| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FIXX | Exit | Homology Medicines, Inc. | $0 | – | -64,000 | -100.0% | -0.17% | – |
| IKNA | Exit | Ikena Oncology, Inc. | $0 | – | -26,833 | -100.0% | -0.26% | – |
| SPRO | Exit | Spero Therapeutics, Inc. | $0 | – | -249,070 | -100.0% | -0.68% | – |
| DTIL | Exit | Precision BioSciences, Inc. | $0 | – | -1,123,913 | -100.0% | -0.86% | – |
| Exit | eFFECTOR Therapeutics, Inc. | $0 | – | -1,025,697 | -100.0% | -1.38% | – | |
| VOR | Exit | Vor Biopharma Inc. | $0 | – | -374,714 | -100.0% | -1.79% | – |
| SELB | Exit | Selecta Biosciences, Inc. | $0 | – | -862,543 | -100.0% | -2.06% | – |
| GRPH | Exit | Graphite Bio | $0 | – | -406,308 | -100.0% | -2.27% | – |
| PMVP | Exit | PMV Pharmaceuticals, Inc. | $0 | – | -989,232 | -100.0% | -13.66% | – |
| CYT | Exit | Cyteir Therapeutics, Inc. | $0 | – | -2,459,572 | -100.0% | -15.71% | – |
| AVTE | Exit | Aerovate Therapeutics Inc. | $0 | – | -603,762 | -100.0% | -18.42% | – |
| CNTA | Exit | Centessa Pharmaceuticals plcsponsored ads | $0 | – | -2,937,615 | -100.0% | -42.74% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Centessa Pharmaceuticals plc | 8 | Q3 2023 | 42.7% |
| Aerovate Therapeutics Inc. | 8 | Q3 2023 | 28.9% |
| PMV Pharmaceuticals, Inc. | 8 | Q3 2023 | 19.4% |
| Cyteir Therapeutics, Inc. | 8 | Q3 2023 | 15.7% |
| Vor Biopharma Inc. | 8 | Q3 2023 | 4.1% |
| Precision BioSciences, Inc. | 8 | Q3 2023 | 3.7% |
| Graphite Bio | 8 | Q3 2023 | 2.3% |
| eFFECTOR Therapeutics, Inc. | 8 | Q3 2023 | 3.8% |
| Selecta Biosciences, Inc. | 8 | Q3 2023 | 2.4% |
| Spero Therapeutics, Inc. | 8 | Q3 2023 | 1.8% |
View OUP Management Co., LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-04-24 |
| 13F-HR | 2023-02-02 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-19 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-03 |
View OUP Management Co., LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.